Purple Biotech Reports Fourth Quarter and Full-Year 2022
Expands pipeline with acquisition of new tri-specific antibodies Data readouts for two lead clinical programs expected in 2023 REHOVOT, Israel, Feb. ...
Source: globenewswire.com
Page 30 - Registration Statements News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Registration Statements. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Registration Statements Today - Breaking & Trending Today
DEADLINE: Investors in Y-mAbs Therapeutics, Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) common stock on the open...
Source: prnewswire.com
YMAB INVESTOR NOTICE: Robbins Geller Rudman & Dowd
SAN DIEGO, Jan. 22, 2023 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Y-mAbs Therapeutics, Inc....
Source: globenewswire.com
The Law Offices of Timothy L. Miles Informs Investors of a Class Action Lawsuit Against Y-mAbs Therapeutics, Inc.
Class action lawsuit charges Y-mAbs and certain of its top executive officers with violations of the Securities Exchange Act of 1934
Source: einnews.com
The Law Offices of Timothy L. Miles Informs Investors of a Class Action Lawsuit Against Y-mAbs Therapeutics, Inc.
Class action lawsuit charges Y-mAbs and certain of its top executive officers with violations of the Securities Exchange Act of 1934
Source: einnews.com